Related Experiment Video
Updated: Aug 10, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Use of CpG DNA for enhancing specific immune responses
1Loeb Health Research Institute, Ottawa, ON, Canada. hdavis@LRI.ca
Abstract:
CpG ODN, owing to its wide range of immunostimulatory effects has been found to be a potent Th1-type adjuvant that is effective with virtually any type of antigen, although responses are less impressive with PS than protein antigens. The use of CpG ODN as an adjuvant may allow the development of vaccines against a wider range of diseases, which could include therapeutic vaccines for chronic infections or cancer, effective pediatric vaccines for newborns, and easily delivered mucosal vaccines.
Related Concept Videos
Recombinant DNA
CRISPR
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
CRISPR/Cas9 Genome Editing

